Close Notification

Your cart does not contain any items

Time Ships

Stephen Baxter



We can order this in for you
How long will it take?


20 June 2016
Science fiction; Science; Time Travel
The highly-acclaimed sequel to H G Wells's The Time Machine, from the heir to Arthur C. Clarke. Written to celebrate the centenary of the publication of H G Wells's classic story THE TIME MACHINE, Stephen Baxter's stunning sequel is an outstanding work of imaginative fiction. The Time Traveller has abandoned his charming and helpless Eloi friend Weena to the cannibal appetites of the Morlocks, the devolved race of future humans from whom he was forced to flee. He promptly embarks on a second journey to the year AD 802,701, pledged to rescue Weena. He never arrives. The future was changed by his presence... and will be changed again. Hurling towards infinity, the Traveller must resolve the paradoxes building around him in a dazzling temporal journey of discovery. He must achieve the impossible if Weena is to be saved.
By:   Stephen Baxter
Imprint:   Voyager
Country of Publication:   United Kingdom
Dimensions:   Height: 198mm,  Width: 129mm,  Spine: 33mm
Weight:   350g
ISBN:   9780008134549
ISBN 10:   0008134545
Publication Date:   20 June 2016
Audience:   General/trade ,  ELT Advanced
Format:   Paperback
Publisher's Status:   Active

Reviews for Time Ships

`Stephen Baxter really does stand on the shoulders of giants in order to see further than they did ... THE TIME SHIPS is a brilliant piece of work. It is a sequel in the best possible sense.' Interzone `The most outstanding work of imaginative fiction since Stapleton's LAST AND FIRST MEN ... I'm almost tempted to say (I know this is blasphemy) that the sequel is better than the original ...' Arthur C. Clark `Arthur C. Clarke, Isaac Asimov and Robert Heinlein succeeded in doing it, but very few others. Now Stephen Baxter joins their exclusive ranks. The reaction is that which C. S. Lewis referred to when he described science fiction as the only genuine consciousness-expanding drug.' New Scientist

See Also